Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Safeguard Your Portfolio: 3 Stocks to Sell in 2023

By Chris Markoch, InvestorPlace Contributor

With so much volatility in the economy, the gains in January may get wiped away. So now is the time for you to look at stocks to sell

The 7 Most Undervalued Blue-Chip Stocks to Buy in February 2023

By Chris Markoch, InvestorPlace Contributor

If you're looking for undervalued blue-chips, we've come up with a list of seven stocks that you can consider adding in February

The 3 Most Undervalued Penny Stocks to Buy in February 2023

By Chris Markoch, InvestorPlace Contributor

Here are three penny stocks in emerging sectors that look to be undervalued relative to the consensus price target of analysts.

7 Dividend Stocks to Buy Now or You’ll Be Kicking Yourself Later

By Chris Markoch, InvestorPlace Contributor

Dividend stocks are a hedge against volatile markets. Here are seven dividend stocks that you should buy now before you regret missing out.

3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later

By Chris Markoch, InvestorPlace Contributor

Even in a risk-off market, gene editing stocks look attractive. Here are three stocks that may be worth a closer look at this time.

Load More